Table 5 The diagnostic manifestations for LR-3/LR-4 lesions in HCC group and Non-HCC group base on AF-HCC and AF-LR
Variable | level | Overall | HCC group (LR-3/4 n = 133) | Non-HCC group (LR-3/4 n = 149) | Sensitivity (%) | Specificity (%) | Kappa test | P |
|---|---|---|---|---|---|---|---|---|
(a) Based on ancillary features screened from all lesions | 0.695 | 0.000 | ||||||
Degrade | 5.7(16/282) | 0.0 (0/133) | 10.7(16/149) | 84.96 (113/133) | 89.26 (133/149) | |||
Retain | 32.6(92/282) | 15.0(20/133) | 48.3(72/149) | |||||
Upgrade | 61.7(174/282) | 85.0(113/133) | 40.9(61/149) | |||||
(b) Based on ancillary features screened from LR-3/LR-4 lesions | ||||||||
Degrade | 5.3(15/282) | 0.8(1/133) | 9.4(14/149) | 85.71 (114/133) | 90.60 (135/149) | |||
Retain | 29.4(83/282) | 13.5(18/133) | 43.6(65/149) | |||||
Upgrade | 65.2(184/282) | 85.6(114/133) | 47.0(70/149) | |||||